KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Gross Margin (2018 - 2025)

ClearPoint Neuro's Gross Margin history spans 13 years, with the latest figure at 63.2% for Q3 2025.

  • For Q3 2025, Gross Margin rose 352.0% year-over-year to 63.2%; the TTM value through Sep 2025 reached 61.31%, up 93.0%, while the annual FY2024 figure was 60.92%, 409.0% up from the prior year.
  • Gross Margin for Q3 2025 was 63.2% at ClearPoint Neuro, up from 60.29% in the prior quarter.
  • Across five years, Gross Margin topped out at 74.36% in Q4 2021 and bottomed at 52.54% in Q2 2023.
  • The 5-year median for Gross Margin is 62.6% (2022), against an average of 62.71%.
  • The largest annual shift saw Gross Margin tumbled -3121bps in 2021 before it soared 1094bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 74.36% in 2021, then fell by -13bps to 65.06% in 2022, then dropped by -9bps to 58.93% in 2023, then increased by 4bps to 61.28% in 2024, then increased by 3bps to 63.2% in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Gross Margin are 63.2% (Q3 2025), 60.29% (Q2 2025), and 60.48% (Q1 2025).